ITEM VIEW

Pharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations

dc.contributor.authorThee S.
dc.contributor.authorSeddon J.A.
dc.contributor.authorDonald P.R.
dc.contributor.authorSeifart H.I.
dc.contributor.authorWerely C.J.
dc.contributor.authorHesseling A.C.
dc.contributor.authorRosenkranz B.
dc.contributor.authorRoll S.
dc.contributor.authorMagdorf K.
dc.contributor.authorSchaaf H.S.
dc.date.accessioned2012-01-18T08:06:33Z
dc.date.available2012-01-18T08:06:33Z
dc.date.issued2011
dc.identifier.citationAntimicrobial Agents and Chemotherapy
dc.identifier.citation55
dc.identifier.citation12
dc.identifier.citationhttp://www.scopus.com/inward/record.url?eid=2-s2.0-81555201905&partnerID=40&md5=8469a08b4be212c62f012ce8e4d4f7ed
dc.identifier.issn664804
dc.identifier.other10.1128/AAC.05429-11
dc.identifier.urihttp://hdl.handle.net/10019.1/19107
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.subjectbe tabs
dc.subjectcotrimoxazole
dc.subjectisoniazid
dc.subjectlamivudine
dc.subjectlopinavir plus ritonavir
dc.subjectpyrazide
dc.subjectpyrazinamide
dc.subjectrifampicin
dc.subjectrimcure
dc.subjectritonavir
dc.subjectstavudine
dc.subjectunclassified drug
dc.subjectabdominal infection
dc.subjectacetylator phenotype
dc.subjectarea under the curve
dc.subjectarticle
dc.subjectchild
dc.subjectclinical article
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectdose response
dc.subjectdrug blood level
dc.subjectdrug dose comparison
dc.subjectextrapulmonary tuberculosis
dc.subjectfemale
dc.subjectgenotype
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infection
dc.subjectinfant
dc.subjectlung tuberculosis
dc.subjectmale
dc.subjectmaximum plasma concentration
dc.subjectmixed infection
dc.subjectnutritional status
dc.subjectobservational study
dc.subjectpreschool child
dc.subjectpriority journal
dc.subjectprospective study
dc.subjectrecommended drug dose
dc.subjecttime to maximum plasma concentration
dc.subjecttuberculous meningitis
dc.subjectworld health organization
dc.titlePharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

ITEM VIEW